Found: 11
Select item for more details and to access through your institution.
The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 9, p. 2499, doi. 10.1007/s13300-021-01125-8
- By:
- Publication type:
- Article
Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01879-4
- By:
- Publication type:
- Article
Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial.
- Published in:
- Cardiovascular Diabetology, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12933-020-01206-1
- By:
- Publication type:
- Article
Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 5, p. 999, doi. 10.1007/s13300-017-0292-1
- By:
- Publication type:
- Article
Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study.
- Published in:
- Cardiovascular Diabetology, 2020, v. 19, n. 1, p. 1, doi. 10.1186/s12933-020-01079-4
- By:
- Publication type:
- Article
Contribution of Asian Haplotype of KCNJ18 to Susceptibility to and Ethnic Differences in Thyrotoxic Periodic Paralysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Vascular complications and changes in body mass index in Japanese type 2 diabetic patients with abdominal obesity.
- Published in:
- Cardiovascular Diabetology, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1475-2840-12-88
- By:
- Publication type:
- Article
Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using DPP-4 inhibitor: the Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE)
- Published in:
- Diabetology & Metabolic Syndrome, 2014, v. 6, n. 1, p. 1, doi. 10.1186/1758-5996-6-35
- By:
- Publication type:
- Article
Clinical and endocrinological characteristics of adrenal incidentaloma in Osaka region, Japan.
- Published in:
- Endocrine Journal, 2016, v. 63, n. 1, p. 29, doi. 10.1507/endocrj.ej15-0404
- By:
- Publication type:
- Article
Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes Care 2016;39:455-464.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article